Neutropenia: clinical implications and modulation.
Glauser
M P
MP
Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects; D001424:Bacterial Infections / Q000209:etiology* / Q000517:prevention & control*; D005334:Fever / Q000188:drug therapy / Q000209:etiology; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D009503:Neutropenia / Q000150:complications* / Q000209:etiology / Q000628:therapy*; D012772:Shock, Septic / Q000209:etiology / Q000628:therapy
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D006133:Growth Substances